RxDoctor Payments Data

Krishna Komanduri

Hematology & Oncology · Miami, FLNPI 1598850265

Payments from drug & device makers

$187,229in general payments, 2019–2025

Across 143 payments — averaging $1309.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$67K
  • Gilead$32K
  • Sanofi-aventis U.S. LLC$15K
  • Sanofi$14K
  • Genentech, Inc.$14K
  • Janssen Scientific Affairs, LLC$9K
  • plus $36K from 11 others
$13,521in research payments, 2019–2025

Across 2 payments — averaging $6760.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$8K
  • F. Hoffmann-la Roche AG$5K

What the payments were for

  • Consulting fees$160,10786%
  • Speaking & faculty fees$7,8554%
  • Travel & lodging$15,2478%
  • Food & beverage$4,0202%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$187,229 in reported general payments places this provider in the 70th percentile of 694 hematology & oncology providers in Florida.

See all hematology & oncology providers in Florida

Other hematology & oncology in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →